Bharat Biotech has teamed up with ViroVax to use the US scientific
research firm's adjuvant for boosting the immune response and
providing long-lasting immunity to its novel vaccine candidate
Covaxin, which has entered phase-2 human trials.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bharat-biotech-to-use-virovaxs-adjuvant-in-covid-vaccine/articleshow/78505253.cms
Monday, October 5, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment